eli lilly glp 1 pill FDA approves new weight-loss pill, Foundayo Eli Lilly’s experimental pill, orforglipron,
Description
Semaglutide may be appropriate if you: Have a body mass index (BMI) of 27 or higher with weight-related health conditions Struggle with hunger, cravings, or portion control Have tried dieting and exercise without lasting success Are looking for a physician-supervised, non-surgical weight loss option Our medical team conducts a thorough consultation to evaluate your health history and goals before beginning treatment
Members lose 29% more weight with Med+ At 12 months, Med+ members prescribed a GLP-1 medication who engaged regularly with the GLP-1 Success Program lost 29.1% more body weight , on average, than those who did not engage in behavioral support*
Fill out a 510 minute health history: Choose a treatment plan
Get ongoing support
doi: 10.1016/j.bcp.2021.114723
Secher A, Jelsing J, Baquero AF, Hecksher-Sorensen J, Cowley MA, Dalboge LS, Hansen G, Grove KL, Pyke C, Raun K, et al
